Beam Therapeutics Inc. Revenue 2019–2025
Beam Therapeutics Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Beam Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 31.7 M, a 324.87% increase year-over-year.
- Beam Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 57.4 M, a 13.28% increase year-over-year.
- Beam Therapeutics Inc. annual revenue for 2025 was 139.7 M, a 120.01% increase from 2024.
- Beam Therapeutics Inc. annual revenue for 2024 was 63.5 M, a 83.18% decrease from 2023.
- Beam Therapeutics Inc. annual revenue for 2023 was 377.7 M, a 520.01% increase from 2022.
- Beam Therapeutics Inc. annual revenue for 2022 was 60.9 M.
Beam Therapeutics Inc. (BEAM) — Frequently Asked Questions
Beam Therapeutics Inc. (BEAM) is a publicly traded US company. It has a market capitalization of $2.92B. In fiscal 2025 it reported revenue of $140M and net income of -$80M. Explore BEAM's stock price, financial statements, earnings history, margins and key ratios below.
What is Beam Therapeutics Inc.'s market cap?
Beam Therapeutics Inc. (BEAM) has a market capitalization of $2.92B.
What is the BEAM stock price?
BEAM trades at $29.49 (-3.22% on the day).
How much revenue does Beam Therapeutics Inc. make?
Beam Therapeutics Inc. reported revenue of $140M in fiscal 2025.
Is BEAM profitable?
In fiscal 2025, Beam Therapeutics Inc. reported net income of -$80M.